...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Note

On Friday, March 5th (posted on SEDAR March 8th as an Exempt Distribution) there was a transaction for a Promissory Note worth $1,900,200 CAD with a Chinese party. The transaction was made in USD so was probably for $1.5 million USD.

Share
New Message
Please login to post a reply